A new study points to specific changes companies can make in clinical trials so that, in the future, clearer data can lead us closer to a cure.
The research presented brings the promise of better outcomes for pregnant women with lupus and their babies.
Not all patients who share a certain organ involvement can be treated with the same medicine at the same dose. In this piece, Foundation Medical Director Dr. Joan Merrill argues that improved classification of lupus can lead to better treatment.
Further studies may lead to interventions that improve the health outcomes of people with lupus.
A new study conducted by researchers at Children’s Hospital of Philadelphia takes a closer look at depression and anxiety in children with lupus.
Foundation grantees Dr. Jill Buyon and Dr. Jane Salmon recently presented results from their research on pregnancy in women with lupus. Read more.
April 1 is the deadline for late-breaking abstract submissions and for registration by poster presenters at the Federation of Clinical Immunology Societies (FOCiS) Annual Meeting June 24-27 in San Diego.
LFA-REAL aims to improve health and quality of life for people with lupus.